Universe · entity
Lion Point Capital, LP
Institutional manager (13F) · CIK 1643354
13F holdings · as of 2026-03-31 · top 35 · reported portfolio $17M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | PRAXIS PRECISION MEDICINES I | $1M | 4,450 |
| 2 | MOONLAKE IMMUNOTHERAPEUTICS | $1M | 67,500 |
| 3 | ROYALTY PHARMA PLC | $1M | 21,400 |
| 4 | MILESTONE PHARMACEUTICALS IN | $976k | 820,000 |
| 5 | GERON CORP | $861k | 578,000 |
| 6 | SYNDAX PHARMACEUTICALS INC | $841k | 36,000 |
| 7 | ARDELYX INC | $771k | 128,650 |
| 8 | FENNEC PHARMACEUTICALS INC | $691k | 112,434 |
| 9 | BENITEC BIOPHARMA INC | $660k | 62,000 |
| 10 | SAREPTA THERAPEUTICS INC | $620k | 28,500 |
| 11 | DISC MEDICINE INC | $518k | 8,100 |
| 12 | CUE BIOPHARMA INC | $506k | 2,202,854 |
| 13 | COMPASS PATHWAYS PLC | $442k | 80,000 |
| 14 | BIOHAVEN LTD | $437k | 51,700 |
| 15 | LANTHEUS HLDGS INC | $417k | 5,500 |
| 16 | JASPER THERAPEUTICS INC | $407k | 465,000 |
| 17 | HUMACYTE INC | $394k | 650,000 |
| 18 | VIATRIS INC | $374k | 27,700 |
| 19 | KURA ONCOLOGY INC | $374k | 46,000 |
| 20 | BRIDGEBIO PHARMA INC | $371k | 5,000 |
| 21 | DYNE THERAPEUTICS INC | $326k | 18,000 |
| 22 | ROCKET PHARMACEUTICALS INC | $308k | 86,000 |
| 23 | PACIRA BIOSCIENCES INC | $305k | 13,500 |
| 24 | EDGEWISE THERAPEUTICS INC | $287k | 9,100 |
| 25 | MINERALYS THERAPEUTICS INC | $284k | 10,500 |
| 26 | SERES THERAPEUTICS INC | $280k | 31,570 |
| 27 | JANUX THERAPEUTICS INC | $264k | 19,000 |
| 28 | UNIQURE NV | $240k | 14,700 |
| 29 | REGENXBIO INC | $223k | 26,600 |
| 30 | AZENTA INC | $205k | 9,700 |
| 31 | INNOVIVA INC | $191k | 8,200 |
| 32 | GH RESEARCH PLC | $143k | 10,200 |
| 33 | ARCUTIS BIOTHERAPEUTICS INC | $124k | 5,250 |
| 34 | INNATE PHARMA S A | $104k | 81,151 |
| 35 | SPRUCE BIOSCIENCES INC | $65k | 1,000 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.